LLY Eli Lilly and Company

USD 734.97 0.00 0
Icon

Eli Lilly and Company (LLY) Stock Analysis and Price Targets

COMMON STOCK | Drug Manufacturers - General | NYE
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Neutral

Stock Target Advisor
Analysis
stockTargetAdvisor

Buy

Average User
Rating

USD 734.97

0.00 (0.00)%

USD 745.60B

4.59M

USD 811.76(+10.45%)

USD 407.37 (-44.57%)

Icon

LLY

Eli Lilly and Company (USD)
COMMON STOCK | NYE
USD 734.97
0.00 0
Take a Tour

Eli Lilly and Company (LLY) Stock Forecast

USD 811.76
(+10.45%)

Based on the Eli Lilly and Company stock forecast from 14 analysts, the average analyst target price for Eli Lilly and Company is USD 811.76 over the next 12 months. Eli Lilly and Company’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Eli Lilly and Company is Neutral, which is based on 9 positive signals and 9 negative signals. At the last closing, Eli Lilly and Company’s stock price was USD 734.97. Eli Lilly and Company’s stock price has changed by +0.20% over the past week, -4.31% over the past month and +71.55% over the last year.

Analyst Ratings

Target Price Action Rating Action Analyst Rating Price Date

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...